Judge tosses radiopharmacy suit against GE, Cardinal Health
A California judge tosses PharmaRx Pharmaceuticals' lawsuit accusing GE and Cardinal Health of conspiring to monopolize the market for cardiac imaging agents.
A federal judge in California tossed a radiopharmacy's lawsuit against GE  (NYSE:GE ) and Cardinal Health  (NYSE:CAH ), ruling that PharmaRx Pharmaceuticals failed to prove its allegations of a conspiracy to monopolize the market for cardiac imaging agents.
PharmaRx sued the 2 companies in March, alleging that their co-marketing deal for GE's Myoview imaging agent violates antitrust statutes.
Judge Maria Pfaelzer of the U.S. District Court for Central California dismissed the case without prejudice, giving PharmaRx the chance to file another complaint. Pfaelzer ruled that PharmaRx didn't provide the evidence of implicit collusion required to prove its case.